Examining the Role of Pharmacokinetics in Hemophilia

Slides:



Advertisements
Similar presentations
The role of the nurse in OHPAT Jill Kayley Independent Nurse Consultant.
Advertisements

“ To bleed or not to bleed ” Developing Individualized Treatment Plans for Adult Patients with Hemophilia 1 Adult Hemophilia Program of BC, St. Paul’s.
Standard 5 Implementation The registered nurse implements the identified plan.
ПОРТФОЛИО профессиональной деятельности Белово 2015 Таюшовой Натальи Борисовны Преподавателя дисциплин «Химия», «Биология»
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.
CONTROLLING THE COSTS OF HEMOPHILIA
The Nurse’s Role in Inflammatory Bowel Disease
Education program ( system). Education program ( system)
Sites of Action in Coagulation System Novel Factor Xa and DT Inhibitors.
Using pharmacokinetics to individualize hemophilia therapy
Challenges and Opportunities in the Management of ANCA-Associated Vasculitis.
NOACs for Cancer-Associated Thrombosis:
Prophylaxis Considerations for Teenagers and Young Adults With Severe Hemophilia.
This program will include a discussion of off-label treatment and devices and investigational agents and devices not approved by the FDA for use in the.
The Comprehensive Major Depressive Disorder Care Team
Extended Half-life Factor Products in the Management of Hemophilia
Individualizing Prophylaxis in Hemophilia
Hot Topics in Hemophilia Nursing
Mid-Year Hemophilia Update
Working as a Team for Improved Patient Outcomes in Type 2 Diabetes
Issues in the Management of Hemophilia: A Best Practice Series
Organizational Culture in the Oncology Medical Home
Innovative Insulin Combinations: A New strategy for the Person With T2DM.
Optimal Use of New Fentanyl Formulations for BTCP in Asia
Heart Failure Management Coordinated Care Approaches
Chronic Idiopathic Urticaria
Tailoring Hemophilia Prophylaxis Therapy
Asthma and Atopic Comorbidities
What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?
Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.
Talking to Patients About Diabetes Management
Team-Based Perspectives on Successful Approaches in Treating Obesity
Individualizing Factor Replacement Therapy for Patients With Hemophilia.
EHL Technologies in Hemophilia Care
Issues in the Management of Hemophilia: A Best Practice Series
Exploring Personalized Prophylaxis in Hemophilia A
The Science of Gene Therapy for Hemophilia
Battling Constipation
Improving Therapeutic Management of Huntington's Disease in Long-Term Care.
Program Goals. Technological Advances in Longer-Acting Factor Replacement Therapy for Hemophilia.
Multidisciplinary Approaches to Managing Hemophilia
What Does It Take to Be a Long-Acting Replacement Therapy in Hemophilia A?
Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?
Managing CKD-Associated Anemia in Challenging Patients
IgG-Fc Fusion Proteins and Immunomodulation: What Does the Science Tell Us?
Extended Half-life Factor Products in the Management of Hemophilia
Updates From the 2015 Meetings in Hemophilia
Please join us in celebrating. . .
Current Challenges in Managing Hemophilia
The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.
Optimizing Joint Health in Hemophilia
A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.
Etiology and Incidence Pathophysiology Hemophilia is due to a defect in thrombin generation on the platelet surface.
Challenges in LA SCCHN.
The Oncology Care Team.
Treating Atypical Hemolytic Uremic Syndrome A Case Discussion
Assessing the Burden of Hyperkalemia
Jennifer B. Martin, DNP, CRNA  Critical Care Nursing Clinics 
Selecting Treatment Approaches in Hemophilia
Assessing the Burden of Hyperkalemia
Would Patients With Hemophilia B Benefit From Switching to Extended Half-Life Factor Products? 
PAH Pathways: What Do the Data Tell Us?”
Championing Evidence-Based Care in Patients With Acute Low Back Pain
Clinical Pearls in the Management of Patients With Advanced Non-Small Cell Lung Cancer.
Exploring the Use of Adeno-Associated Virus for Gene Therapy
Navigating the Journey
Fresh perspectives ON BASAL Insulins in diabetes care
What's New in NOACs in AF?.
Best Practices in Building HIV Care Networks
The Challenge of Insulin Titration
Presentation transcript:

Examining the Role of Pharmacokinetics in Hemophilia

Role of PK Studies in Patients With Hemophilia

The Science of Pharmacokinetics

Pharmacokinetics

Pharmacokinetic Definitions

Hemophilia Overview

Intermittent Infusions (Bolus)

Continuous Infusions

Half-Life Differences With Types of Factor VIII Deficiency Treatments

Available Extended Half-Life Products for Factor VIII

Half-Life Differences With Types of Factor IX Deficiency Treatments

Available Extended Half-Life Products for Factor IX

Assays for Hemophilia

Factor Dosing General Overview

Clinical Implications of PK Studies in Hemophilia Management

Clinical Implications of PK Studies in Hemophilia Treatment

PK Studies Optimize Treatment

Personalized Prophylaxis

Challenges of PK Studies

Practical Approaches to PK Studies Peak/Trough Levels

Practical Approaches to PK Studies Population PK Studies

Planning Regimen With Patient/Family Factors to Consider

Patient/Family Education

Patient/Family Education and Participation

Practical Implementation

Role of Nurses and Pharmacists in PK Assessment

Comprehensive Hemophilia Care Team

Role of the HTC Team Pharmacist

Role of the HTC Team Nursing

Role of HTC Team (cont)

Closing the Loop

Abbreviations